Activated ras enhances insulin-like growth factor I induction of vascular endothelial growth factor in prostate epithelial cells

Cancer Research

Volumn 65, Issue 6, 2005, Pages 2085-2088

  Stearns, Mark ^a   Tran, Jordan ^a   Francis, Mary Kay ^c   Zhang, Hong ^b   Sell, Christian ^d  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b WISTAR INSTITUTE   (United States)

^c VILLANOVA UNIVERSITY   (United States)

^d LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; RAS PROTEIN; SOMATOMEDIN C; VASCULOTROPIN;

ARTICLE; CANCER RISK; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; ONCOGENE H RAS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELL LINE, TUMOR; EPITHELIAL CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHOPROTEINS; PROSTATIC NEOPLASMS; RAS PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 16844381319     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4100     Document Type: Article

References (19)

1. LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett 2003;195:127-37.
2. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002;277:38205-11.
3. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 2002;277:27975-81.
4. Stoeltzing O, Liu W, Reinmuth N, et al. Regulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. Am J Pathol 2003;163:1001-11.
5. Neid M, Datta K, Stephan S, et al. Role of insulin receptor substrates and protein kinase C-ζ in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells. J Biol Chem 2004;279:3941-8.
6. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987;327:298-303.
7. Carter BS, Epstein JI, Isaacs WB. Ras gene mutations in human prostate cancer. Cancer Res 1990;50:6830-2.
8. Wong-Staal F, Dalla-Favera R, Franchini G, Gelmann EP, Gallo RC. Three distinct genes in human DNA related to the transforming genes of mammalian sarcoma retroviruses. Science 1981;213:226-8.
9. Okada F, Rak JW, Croix BS, et al. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci U S A 1998;95:3609-14.
10. Bright RK, Vocke CD, Emmert-Buck MR, et al. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 1997;57:995-1002.
11. Burroughs KD, Oh J, Barrett JC, DiAugustine RP. Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1? Mol Cancer Res 2003;1:312-22.
12. Zhang H, Hoff H, Sell C. Insulin-like growth factor I-mediated degradation of insulin receptor substrate-1 is inhibited by epidermal growth factor in prostate epithelial cells. J Biol Chem 2000;275:22558-62.
13. Zhang H, Hoff H, Sell C. Downregulation of IRS-1 protein in thapsigargin-treated human prostate epithelial cells. Exp Cell Res 2003;289:352-8.
14. Morgenstern JP, Land H. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res 1990;18:1068.
15. Pietrzkowski Z, Sell C, Lammers R, Ullrich A, Baserga R. Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell Biol 1992;12:3883-9.
16. Lehr JE, Pienta KJ. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst 1998;90:118-23.
17. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
18. Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 2002;62:1030-5.
19. Semenza GL. Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 2003;54:17-28.